Teradyne Inc. stock gains as Wall Street Zen upgrades rating after strong earnings
π Teradyne Inc. stock rose 5.2% to $371.47 on September 18, 2026, following a Wall Street Zen upgrade from Hold to Buy and a strong earnings beat.
π° Revenue jumped 103.9% year over year to $1.33 billion in the quarter ended July 29, 2026, driven by robust demand for test equipment and automation.
π EPS reached $2.47, topping analyst consensus of $2.09 by $0.38 per share, highlighting strong operational momentum.
π¦ The company trades at a premium P/E ratio of 50.96 with a market capitalization of approximately $58.08 billion as of the September 18 close.
π― Analyst consensus stands at Moderate Buy with a price target of $396.80, suggesting roughly 6.8% upside from current levels.
π CEO Gregory Smith sold 4,000 shares under a pre-arranged Rule 10b5-1 trading plan, which is considered routine governance activity.
π The next earnings date is estimated for October 27, 2026, serving as the upcoming checkpoint for revenue and profit trajectory.
π Teradyne shares are currently positioned well above its 52-week low of $117.54 but remain below the 52-week high of $487.91.
- Teradyne Inc. stock gained 5.2% to close at $371.47 after Wall Street Zen upgraded its rating from Hold to Buy, citing robust growth in test equipment demand.
- Revenue surged 103.9% year over year to $1.33 billion in the latest quarter ended July 29, 2026, demonstrating exceptional top-line expansion.
- Earnings per share of $2.47 significantly beat analyst consensus estimates of $2.09 by $0.38 per share, confirming strong profitability.
- The company is extending a strong year-to-date rally driven by its position as an automated test and industrial automation specialist.
- Analyst consensus remains Moderate Buy with a price target of $396.80, implying approximately 6.8% upside potential from the September 18 closing level.
- Teradyne trades at a premium valuation with a P/E ratio of 50.96, which is higher than many peers in the semiconductor equipment space and may limit multiple expansion.
- Five analysts currently rate the stock as Hold, indicating some caution regarding the high valuation relative to growth prospects.